Clinical Trials
6 trialsNCT04335669 2025-09-12
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
Lund University Hospital
Phase 3 Active not recruiting
NCT06355024 2025-07-18
Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer
Fudan University
Phase 2 Completed
NCT06355037 2024-07-08
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
Fudan University
Phase 2 Recruiting
NCT05843292 2023-06-06
NeoSTEP
Shanghai Jiao Tong University School of Medicine
Phase 4 Not yet recruiting
NCT03057600 2022-09-28
Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)
Calithera Biosciences, Inc
Phase 2 Completed
NCT02685306 2017-03-09
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
Peregrine Pharmaceuticals
Phase 2 Withdrawn